ForumIAS LATEST
- 16 June | Failed Before Success: AIR 295 Reveals His UPSC Journey | Click Here to Watch →
- 17 June | How to Write High-Scoring Answers in Hindi Literature Optional | Click Here to Watch →
- 18 June | From Setback to Success: Bhavika Chopra's Rise to AIR 25 | Click Here to Watch →
- 19 June | The Rankforge Challenge (FRC/Tapasya): Truth About UPSC & Coaching by Ayush Sinha | Click Here to Watch →
- 20 June | 150+ Cleared UPSC Prelims from Naugaon, Alwar | The FRC Tapasya Success Story | Click Here to Watch →
News:India and the U.S have decided to work together on vaccine research and testing for COVID-19 under the Indo-U.S. Vaccine Action Program(VAP).
Facts:
- The Indo-US Vaccine Action Programme(VAP) is a bilateral programme established in 1987.
- Aim: To develop and evolve joint R&D projects towards development of safe and efficacious vaccines against some of the major communicable diseases that presently take a large toll in India & USA.
- Nodal Agencies: U.S. National Institutes of Health, Indian Department of Biotechnology(DBT) and Indian Council of Medical Research(ICMR) along with other partners.
Additional Facts:
Global Vaccine Action Plan(GVAP):
- It is a framework adopted at the 65th World Health Assembly in 2012 to achieve the vision of the Decade of Vaccines 2011-2020(DoV).
- Aim: To prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.
